Causes, Analysis of the Sub-evaluating Coronary Syndromes Acute and Disparities in France in Women (CASSANDRE)
|ClinicalTrials.gov Identifier: NCT01394549|
Recruitment Status : Completed
First Posted : July 14, 2011
Last Update Posted : June 21, 2012
Despite efforts of learned societies, community cardiology and more generally of most players in the health, cardiovascular diseases continue to be the leading cause of death among women in France and all over the Western world, there where they fell to second place among men. Clinical practice and the disparity between the sexes are still insufficiently known.
Multicenter observational study on a cross-week comparative basis with men
|Condition or disease|
|Coronary Acute Syndrome|
In France, as in other industrialized countries, ischemic heart disease is a major cause of morbidity and mortality in women. Work to improve epidemiological knowledge, prevention, screening, risk stratification and treatment of ischemic heart disease in women has a potential impact on all the issues listed.
There is therefore a double challenge:
- A public health issue to alert the female population on cardiovascular risk and its consequences, while the female population does not feel concerned by the potential danger.
- A challenge for health professionals so that they have the same thing vis-à-vis the cardiovascular prevention among women and whatever their field of practice.
|Study Type :||Observational|
|Actual Enrollment :||319 participants|
|Official Title:||Causes, Analysis of the Sub-evaluating Coronary Syndromes Acute and Disparities in France in Women|
|Study Start Date :||June 2011|
|Primary Completion Date :||February 2012|
|Study Completion Date :||March 2012|
The study includes all patients hospitalized for acute coronary syndrome during the week selected and who agreed to participate in the study.
- Clinical practices [ Time Frame: 1 day ]To assess clinical practices and disparities between men and women in the management of acute coronary syndrome
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01394549